Contracts › 80NSSC23CA171
80NSSC23CA171: E014042 Sbir Phase Iii Rapid, Low-Cost Nanoligomertm Based Drug-Discovery in Space
Awarded to Sachi Bioworks, Inc. by National Aeronautics and Space Administration.
$5.4Mobligated
$9.6Mpotential value
19 July 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 80NSSC23CA171 |
|---|---|
| Awardee | Sachi Bioworks, Inc. |
| Awarding agency | National Aeronautics and Space Administration |
| Awarding office | NASA SHARED SERVICES CENTER |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AJ14 General Science & Technology R&D Svcs; General Science & Technology; R&D Administrative Expenses |
| Place of performance | CO |
| Offers received | 500 |
| Period of performance | 10 July 2023 to 19 July 2028 |
| Potential end | 19 July 2028 |
| Estimated recompete solicitation | ~Q1 2028 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record